Original ArticleThe Association Between Enhanced Recovery After Cardiac Surgery–Guided Analgesics and Postoperative Delirium
Section snippets
Study Design
The study authors performed a historical cohort study of patient data from a tertiary academic medical institution to examine the associations between ERACS treatments and the development of postoperative delirium, additional organ injuries, and indicators of protracted recovery. This study was approved by the authors’ university's Institutional Review Board, with a waiver of the requirement for written, informed consent, and adhered to the Strengthening the Reporting of Observational Studies
Patient Characteristics
Of the 1,695 total patients, 20 (1.3%) were excluded from the analysis—2 for lack of recorded height and body mass index, 3 for not being admitted to the ICU postoperatively, 3 for dying within the operating room, and 12 for lack of baseline creatinine measurement. A total of 1,000 patients (59.7%) received at least 1 of the 5 ERACS medications, whereas 675 patients (40.3%) did not receive any. Acetaminophen and gabapentin were administered to 465 (27.8%) and 405 (24.2%) patients, respectively.
Discussion
In this single-center, retrospective cohort study of cardiac surgery patients, there was little association between the use of opioid-sparing ERACS medication and the development of delirium. Acetaminophen, however, was associated with nearly half the odds of postoperative delirium. The authors failed to detect any other association between delirium and ERACS treatment.
Postoperative, systematic delirium screening is recommended in the guidelines for perioperative care in cardiac surgery
Conflict of Interest
None.
References (32)
- et al.
Long-term effects of postoperative delirium in patients undergoing cardiac operation: A systematic review
Ann Thorac Surg
(2016) - et al.
Clearly-defined outcomes improve the quality of health outcomes research
Brit J Anaesth
(2019) - et al.
Assessment of a multimodal analgesia protocol to allow the implementation of enhanced recovery after cardiac surgery: Retrospective analysis of patient outcomes
J Clin Anesth
(2019) - et al.
Delirium in the cardiovascular ICU: Exploring modifiable risk factors
Crit Care Med
(2013) - et al.
Review articles: Postoperative delirium: acute change with long-term implications
Anesth Analg
(2011) Delirium in the cardiac surgical ICU
Curr Opin Anaesthesiol
(2014)- et al.
Costs associated with delirium in mechanically ventilated patients
Crit Care Med
(2004) - et al.
Comparison of delirium assessment tools in a mixed intensive care unit
Crit Care Med
(2009) - et al.
Prevalence and risk factors for development of delirium in surgical and trauma intensive care unit patients
J Trauma
(2008) - et al.
Long-term cognitive impairment after critical illness
N Engl J Med
(2013)
Risk factors associated with cognitive decline after cardiac surgery: A systematic review
Cardiovasc Psychiatry Neurol
Report of the substudy assessing the impact of neurocognitive function on quality of life 5 years after cardiac surgery
Stroke
Clinical practice guidelines for the prevention and management of pain, agitation/sedation, delirium, immobility, and sleep disruption in adult patients in the ICU
Crit Care Med
Dexmedetomidine vs midazolam for sedation of critically ill patients: aA randomized trial
JAMA
Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: The MENDS randomized controlled trial
JAMA
Prevalance of delirium with dexmedetomidine compared with morphine based therapy after cardiac surgery: A randomized controlled trial (DEXmedetdomine Compared to Morphine- DEXCOM study)
Anesthesiology
Cited by (2)
Pro: Methadone Should Be Used as a Part of Enhanced Recovery After Cardiac Surgery Protocol
2024, Journal of Cardiothoracic and Vascular AnesthesiaEnhanced Recovery After Cardiac Surgery and Postoperative Delirium: Comment
2023, Journal of Cardiothoracic and Vascular Anesthesia
Dr Frederic T. Billings’ IV research is supported by R01GM11287 from the NIH, and Dr Robert Freundlich's research is supported by K23HL148640 from the NIH-NHLBI and UL1TR002243 from the NCATS.